CRISPR Therapeutics AG (CRSP) Return on Equity [ROE] (2016 - 2026)
CRISPR Therapeutics AG's Return on Equity [ROE] was -25.34% in Q2 2026, up 1.09 percentage points from -26.43% a year earlier and up 5.09 percentage points from the prior quarter.
Powered by 
Analysis
CRISPR Therapeutics AG (CRSP) Return on Equity [ROE] (2016 - 2026) Analysis & Trends
For FY2025, Return on Equity [ROE] at CRISPR Therapeutics AG came in at -30.18%, down 10.98 percentage points from FY2024.
- Return on Equity [ROE] shows a five-year change of -3.38 percentage points (FY2020 to FY2025).
- In earlier years, Return on Equity [ROE] was -19.20% in FY2024 (-11.03 pp), -8.17% in FY2023 (+22.24 pp), -30.42% in FY2022 (-49.01 pp) and 18.59% in FY2021 (+45.39 pp).
- The Q2 2026 figure marks the highest quarterly Return on Equity [ROE] since Q1 2025.
- Compared with a year earlier, Return on Equity [ROE] was higher in two of the last eight quarters, with an average year-over-year change of -7.57 percentage points.
- The best year-over-year quarter for Return on Equity [ROE] over five years was Q4 2021 (a gain of 38.57 percentage points); the worst was Q3 2022 (a drop of 49.76 percentage points).
- Per Business Quant data, CRSP's Return on Equity [ROE] in the three quarters before Q2 2026 was -30.43% (Q1 2026), -30.31% (Q4 2025) and -26.92% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | CRISPR Therapeutics AG | 5.36 Bn | 5.36 Bn | - | -25.34% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -25.34% |
| Mar 31, 2026 | -30.43% |
| Dec 31, 2025 | -30.31% |
| Sep 30, 2025 | -26.92% |
| Jun 30, 2025 | -26.43% |
| Mar 31, 2025 | -20.51% |
| Dec 31, 2024 | -18.92% |
| Sep 30, 2024 | -12.22% |
| Jun 30, 2024 | -13.08% |
| Mar 31, 2024 | -10.95% |
| Dec 31, 2023 | -8.51% |
| Sep 30, 2023 | -19.95% |
| Jun 30, 2023 | -22.66% |
| Mar 31, 2023 | -28.09% |
| Dec 31, 2022 | -33.95% |
| Sep 30, 2022 | -33.66% |
| Jun 30, 2022 | -29.22% |
| Mar 31, 2022 | 13.42% |
| Dec 31, 2021 | 15.38% |
| Sep 30, 2021 | 16.10% |
API Access
CRISPR Therapeutics AG Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CRSP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "CRSP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CRSP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();